These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25982918)

  • 21. Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study.
    Prandoni P
    Eur J Haematol; 2012 Oct; 89(4):281-7. PubMed ID: 22834998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants.
    Hull RD; Gersh MH
    Curr Med Res Opin; 2015 Feb; 31(2):197-210. PubMed ID: 25299352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban for the treatment of pulmonary embolism.
    Vanassche T; Verhamme P
    Adv Ther; 2013 Jun; 30(6):589-606. PubMed ID: 23807375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis.
    Wang X; Zhou YC; Zhu WD; Sun Y; Fu P; Lei DQ; Zhao HY
    J Investig Med; 2017 Dec; 65(8):1136-1146. PubMed ID: 28747317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation in Deep Venous Thrombosis: Current Trends in the Era of Non- Vitamin K Antagonists Oral Anticoagulants.
    Papakonstantinou PE; Tsioufis C; Konstantinidis D; Iliakis P; Leontsinis I; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2692-2702. PubMed ID: 32310041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
    Monreal M; Büller H; Lensing AW; Bonet M; Roncales J; Muchart J; Fraile M
    Thromb Haemost; 2002 Dec; 88(6):938-42. PubMed ID: 12529742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
    Dentali F; Botto GL; Gianni M; Ambrosino P; Di Minno MN
    Int J Cardiol; 2015 Apr; 185():72-7. PubMed ID: 25791094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
    Bookhart BK; Haskell L; Bamber L; Wang M; Schein J; Mody SH
    J Med Econ; 2014 Oct; 17(10):691-5. PubMed ID: 25065536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
    Dentali F; Riva N; Crowther M; Turpie AG; Lip GY; Ageno W
    Circulation; 2012 Nov; 126(20):2381-91. PubMed ID: 23071159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
    Hirschl M; Kundi M
    Vasa; 2014 Sep; 43(5):353-64. PubMed ID: 25147012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
    Squizzato A; Lussana F; Cattaneo M
    Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study.
    Zondag W; Mos IC; Creemers-Schild D; Hoogerbrugge AD; Dekkers OM; Dolsma J; Eijsvogel M; Faber LM; Hofstee HM; Hovens MM; Jonkers GJ; van Kralingen KW; Kruip MJ; Vlasveld T; de Vreede MJ; Huisman MV;
    J Thromb Haemost; 2011 Aug; 9(8):1500-7. PubMed ID: 21645235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data.
    van Leent MW; Stevanović J; Jansman FG; Beinema MJ; Brouwers JR; Postma MJ
    PLoS One; 2015; 10(8):e0135054. PubMed ID: 26241880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.